INSMED INC Accumulated Other Comprehensive Income
INSMED INC (INSM) had Accumulated Other Comprehensive Income of -$3.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.37M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.46M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.00M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$3.37M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.46M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.00M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $1.73M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$902.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$2.29M 10-K · filed 2026-02-19 |
| 2024-09-30 | $547.00K 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$2.83M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$1.64M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$745.00K 10-K · filed 2025-02-20 |
| 2023-09-30 | -$2.08M 10-Q · filed 2023-10-26 |
| 2023-06-30 | -$1.25M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.08M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $756.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | -$1.39M 10-Q · filed 2022-10-27 |
| 2022-06-30 | -$929.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$230.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $968.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $100.00K 10-Q · filed 2021-10-28 |
| 2021-06-30 | $424.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $90.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $193.00K 10-K · filed 2022-02-17 |
| 2020-09-30 | $114.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | -$98.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$47.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | -$10.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$8.00K 10-Q · filed 2019-10-30 |
| 2019-06-30 | -$7.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $30.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$9.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $20.00K 10-Q · filed 2018-10-30 |
| 2018-06-30 | $18.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $39.00K 10-Q · filed 2018-05-02 |
| 2017-12-31 | -$3.00K 10-K · filed 2019-02-22 |
| 2017-09-30 | $34.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$42.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$47.00K 10-Q · filed 2017-05-03 |
| 2016-12-31 | -$65.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | -$5.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $12.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$3.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |